Skip to main content

Closed

PMCB: PharmaCyte Biotech, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC0.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio45.28×

PharmaCyte Biotech, Inc.

PMCBNASDAQ Capital Market·USD·Closed

PharmaCyte Biotech, Inc.

PMCBNASDAQ·USD·Closed

$0.58

−4.00%

$0.58

−$0.02 (4.00%)

52W Range

3thpctl

Volume

0.85×avg

Mkt Cap

3.91MUSD

P/E

-0.6TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.85×avg

Market Cap

3.91MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings